Medial EalrySign develops AI-based clinical decision-support and population health solutions. We focus on the early prediction of clinical outcomes related to cancers, metabolic, immune and infectious diseases by applying machine learning algorithms on basic medical information, such as blood test results, medications and other EMR data. Our goal is to make these insights accessible by all stakeholders including healthcare organizations, doctors, and eventually patients

Visit website

Buttontwitter

As Featured In

Original
Original
Original
Original
Original
Original
Original
Original
Original
Original
Original
Original
Original
Original

Partners & Attendees

Intel.001
Nvidia.001
Acc1.001
Ibm watson health 3.001
Facebook.001
Rbc research.001
Mit tech review.001
Graphcoreai.001
Maluuba 2017.001
Twentybn.001
Forbes.001
Kd nuggets.001
This website uses cookies to ensure you get the best experience. Learn more